Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) from ...

Kronos Bio (KRON – Research Report) received a Hold rating and price target from TD Cowen analyst Tyler Van Buren yesterday. The ...

The demand requirements of data centers are creating a challenge and an opportunity for investors around the world.

Spirit Airlines ( SAVE) stock plunged as much as 64% early Wednesday, the most on record, as the budget airline explores a ...

Uncertainty about how US President-elect Donald Trump will apply tariffs has prompted an analyst at Toronto-Dominion Bank to ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of $383.00. The company’s shares closed yesterday at $298.84.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.33% of ...

Shares of Coty (NYSE: COTY) traded lower in pre-market trading on Wednesday after TD Cowen analysts downgraded the beauty ...

Chris Krueger, MD, TD Cowen Washington Research Group, shares his thoughts on Trump’s policies when he takes office again in ...

We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

TD Cowen analyst Brian Morrison downgraded Linamar Corp. to hold from buy, in part because “tariff uncertainty is bound to ...

Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...